This graph illustrates the network of our lab’s publications and collaborators, highlighting the collaborative structure of our research. The network is bipartite, consisting of two types of nodes: Authors (green) and Publications (blue). 

Each line connects an author to a paper they have co-authored, showing the direct relationships between researchers and their work. This map provides a clear view of how our lab’s projects link different scientists, creating a network of collaboration that reflects the scope and connectivity of our research efforts.

1.  Kumar D, Tyagi S, Mukherjee A#, Kumar S#. Harnessing Dual Therapeutic Properties of Phytoconstituents with Anti-HIV and Anti-Cancer Activities. Next Research. 2025; Article in Press. 

2.  Ash K, Harshithkumar R, Chandane-Tak M, Mukherjee A#, Pattnaik A, Mohanty S, Diwedi M, Dev A#. Co-delivery of dolutegravir and carbon-nanoparticles using niosomal platform for enhanced anti-HIV and pharmacokinetic activity. Eur J Pharm Biopharm. 2025; 219:114963. 

3.  Chandane-Tak M, Suneesh NS, Mukherjee S, Khan AA, Mukherjee A#. Network-based integration of hsa-miR-150-5p reveals key regulatory roles in HIV-HCV coinfection and HCV-associated hepatocellular carcinoma. Virology. 2025; 615:110747. 

4.  Dass D, Banerjee A, More A, Mukherjee A#. MicroRNAs as Regulators of NLRP3 Inflammasome Activation in Herpes Simplex Virus Type 2 Infection. Front. Cell Infect Microbiol. 2025; 15:1602965.

5.  Harshithkumar R, Kaul M, Chandane-Tak M, Siddiqi NJ, Malik A, Khan AA#, Mukherjee A#. Harnessing miRNA dynamics in HIV-1-infected macrophages: Unveiling new targeted therapeutics using systems biology. Computational and Structural Biotechnology Journal. 2025; 27: 1754 - 1771.

6.  Suneesh NS, Dhotre K, Mahajan P, Dass D, Banerjee A, Siddiqi NJ, Malik A, Joshi M, Khan AA, Nema V, Mukherjee A#. Reverse vaccinology-based design of multivalent multiepitope mRNA vaccines targeting key viral proteins of Herpes Simplex Virus type-2. Front. Immunol. 2025; 16:1586271. 

7.  Gaikwad SY, More A, Seniya C, Verma K, Chandane-Tak M, Nema V, Kumar S#, Mukherjee A#. Synergistic inhibition of HIV-1 by Nelfinavir and Epigallocatechin Gallate: A novel nanoemulsion-based therapeutic approach. Virology. 2025; 603:110391. 

8.  Banerjee A, Dass D, Mukherjee S, Kaul M, Harshithkumar R, Bagchi P, Mukherjee A#. The ‘Oma’s of the Gammas–Cancerogenesis γ-Herpesviruses. Viruses 2024; 16(12):1928. 

9.  Tyagi S, Gaikwad S, Chandane-Tak M, Mukherjee A#, Kumar S#. Optimization of dolutegravir and Epigallocatechin gallate loaded nanoemulsion for enhanced oral delivery in NeuroAIDS management. J Drug Deliv Sci Technol. 2024; 101: 106293. 

10.  Jadaun P, Harshithkumar R, Seniya C, Gaikwad SY, Bhoite SP, Chandane-Tak M, Borse S, Chavan-Gautam P, Tillu G, Mukherjee A#. Mitochondrial resilience and antioxidant defence against HIV-1: unveiling the power of Asparagus racemosus extracts and Shatavarin IV. Front Microbiol. 2024; 15:1475457. 

11.  Mukherjee A# and Bagchi P#. Editorial: Exploring the Frontiers of Virus–Host Interactions - 3rd Edition. Viruses. 2024; 16(10);1544. 

12.  Verma K, Chandane-Tak M, Gaikwad S, Mukherjee A#, Kumar S#. Optimizing rosemary oil nanoemulsion loaded with nelfinavir and epigallocatechin gallate: A Design Expert® endorsed approach for enhanced neuroAIDS management. Int. J. Biol. Macromol. 2024; 280(3):135885. 

13.  Dass D, Banerjee A, Dhotre K, Sonawane V, More A, Mukherjee A#. HSV-2 Manipulates Autophagy Through Interferon Pathway: A Strategy For Viral Survival. Viruses. 2024; 16(9):1383. 

14.  Harshithkumar R, Shah P, Jadaun P, Mukherjee A#. ROS Chronicles in HIV Infection: Genesis of Oxidative Stress, Associated Pathologies, and Therapeutic Strategies. Curr Issues Mol Biol. 2024; 46(8):8852-8873. 

15.  Joshi R, Aithal S, More A, Nema V, Mukherjee A#. Exploring the therapeutic potential of silver nanocomposition of Catharanthus roseus leaves extract for antimi-crobial and antiviral activities: A pilot study. Int J Plant Based Pharma. 2024; 4(2), 101-109. 

16.  Muheem A, Waseem M, Sartaj A, Gaikwad S, More A, Iqubal A, Kumar S, Aldosari E, Baboota S, Mukherjee A#, Ali J#. D-α-Tocopheryl polyethylene glycol succinate-decorated dual drug-loaded lipidic nanocarriers: a strategic approach for targeting lymphatic uptake and p-gp efflux modulation to enhance oral bioavailability in HIV-1 viral reservoirs. J Drug Deliv Sci Technol. 2024; 98:105831. 

17.  Gaikwad S, Tyagi S, Seniya C, More A, Chandane Tak M, Kumar S#, Mukherjee A#. Exploring Antiviral Activity of Nano Emulsified Dolutegravir Coupled Plant Catechin in Cessation of HIV-1 Replication in Cellular Model. FEBS Letters. 2024; 598(15): 1919-1936. 

18.  Shete A, Ghate M, Iwasaki-Hozumi H, Patil S, Shidhaye P, Bai G, Matsuba T, Pharande P, Mahajan B, Randive A, Mukherjee A, Hattori T. Dynamics of Matricellular Protein Levels in Blood Predict Recovery in Patients with Human Immunodeficiency Virus-Tuberculosis Coinfection. Viruses. 2024; 16(5):664. 

19.  Chandane Tak M, Vaidyanathan A, Mukherjee A#. Revolutionizing HIV-1 Viral Load Monitoring in India: The Potential of Dried Blood Spot Analysis for Expanding Access and Improving Care. Healthcare 2024; 12(4):413. 

20.  Rakshit S, More A, Gaikwad S, Seniya C, Gade A, Muley VY, Mukherjee A#, Kamble K#. Role of diosgenin extracted from Helicteres isora L in suppression of HIV-1 replication: An in vitro preclinical study. Heliyon: Cell Press 2024; 10(2):e24350. 

21.  Tyagi S, Baboota S, Gaikwad S, Ali J, Mukherjee A#, Kumar S#. Envisioning the prospect of nanocarriers as an effective management tool against NeuroAIDS. J Drug Deliv Sci Technol. 2024; 91:105274. 

22.  Dhotre K, Dass D, Banerjee A, Nema V, Mukherjee A#. A computational approach for designing and validating small interfering RNA against SARS-CoV-2 variants. Curr Comput Aided Drug Des. 2024; 20(6):876-887. 

23. Kumar S, Taumar D, Gaikwad S, More A, Nema V, Mukherjee A#. Antiretroviral action of Rosemary oil-based Atazanavir formulation and the role of Self-Nanoemulsifying Drug Delivery System in the management of HIV-1 infection. Drug Deliv Transl Res. 2024;14(7):1888-1908. 

24.  Dhotre K, Banerjee A, Dass D, Nema V, Mukherjee A#. An In-silico Approach to Design and Validate siRNA against Monkeypox Virus. Curr Pharma Des. 2023; 29(38): 3060-3072. 

25.  Pawar P, Gokavi J, Wakhare S, Bagul R, Ghule U, Khan I, Ganu V, Mukherjee A, Shete A, Rao A, Saxena V. MiR-155 Negatively Regulates Anti-Viral Innate Responses among HIV-Infected Progressors. Viruses. 2023; 15(11):2206. 

26.  Mutalik SP, Gaikwad SY, Fernandes G, More A, Kulkarni S, Fayaz SMA, Tupally K, Parekh HS, Kulkarni S#, Mukherjee A#, Mutalik S#. Anti-CD4 antibody and dendrimeric peptide based targeted nano-liposomal dual drug formulation for the treatment of HIV infection. Life Sci. 2023; 334:122226. 

27.  Banerjee A, Dass D, Dhotre K, Wakchoure P, More A, Rana S, Khan AA#, Mukherjee A#. Combinatorial Effects of miRNAs in HSV-2 Infection of Macrophages: An In Silico and In Vitro Integration Approach. Vaccines. 2023; 11(9):1488. 

28.  Mukherjee A# and Bagchi P#. Editorial: Host Cell-Virus Interaction 2.0: Viral Stratagems of Immune Evasion, Host Cellular Responses and Antiviral Counterattacks. Viruses, 2023; 15(8):1717. 

29.  Jadaun P, Harshithkumar R, Gaikwad SY, Seniya C, Borse S, Gawai AA, Chavan-Gautam P, Tillu G, Mukherjee A#. Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection. Virol J. 2023; 20(1):173. 

30.  Shinde MD, Patil SA, Mukherjee A, Nema V. Revisiting the therapeutic potential of homeopathic medicine RhusTox for Herpes simplex virus and inflammatory conditions. J Ayurveda Integr Med. 2023; 14(4):100739. 

31.  Gaikwad SY, Phatak P, Mukherjee A#. Cutting edge strategies for screening of novel anti-HIV drug candidates against HIV infection: A concise overview of cell based assays. Heliyon: Cell Press 2023; 9:e16027. 

32.  Kamble S, Shidhaye P, Mukherjee A, Tak MC, Bembalkar S, Aggarwal S, Deb A, Kapoor N, Verma V, Das C, Kulkarni S, Ghate M, Godbole S. A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 Viral Load testing among the people living with HIV attending ART centers in India. PLoS ONE, 2023; 18(5):e0285942. 

33.   Khan I, Harshithkumar R, More A, Mukherjee A#. Human Papilloma Virus: An Unraveled Enigma of Universal Burden of Malignancies. Pathogens 2023;12(4):564. 

34.  Jadaun P, Shah P, Harshithkumar R, Said MS, Bhoite SP, Bokuri S, Ravindran S, Mishra N, Mukherjee A#. Antiviral and ROS scavenging potential of Carica papaya Linn and Psidium guajava leaves extract against HIV-1 infection. BMC Complement Med Ther. 2023;23(1):82. 

35.  Dass D, Dhotre K, Chakraborty M, Nath A, Banerjee A, Bagchi P, Mukherjee A#. miRNAs in Herpesvirus Infection: Powerful Regulators in Small Packages. Viruses. 2023;15(2):429. 

36.  Jadaun P, Seniya C, Pal SK, Kumar S, Kumar P, Nema V, Kulkarni SS, Mukherjee A#. Elucidation of Antiviral and Antioxidant Potential of C-Phycocyanin against HIV-1 Infection through In Silico and In Vitro Approaches. Antioxidants (Basel). 2022;11(10):1942. 

37.  Panda K and Mukherjee A#. Is monkeypox a threat to another pandemic? Front. Microbiol. 2022; 13:983076. 

38.  Joshi N, Chandane-Tak M and Mukherjee A#. The Involvement of microRNAs in HCV and HIV Infection. Ther Adv Vaccines Immunother. 2022; 10: 1-19. 

39.  Bhuinya A, Dass D, Banerjee A, Mukherjee A#. A tale of antiviral counterattacks in rotavirus infection. Microbiol Res. 2022; 260:127046. 

40.  Mukherjee A# and Bagchi P#. Editorial: Host Cell-Virus Interaction. Viruses, 2022; 14(3):615. 

41.  Banerjee A, Chawla-Sarkar M and Mukherjee A#. Rotavirus-Mediated Suppression of miRNA-192 Family and miRNA-181a Activates Wnt/β-Catenin Signaling Pathway: An In Vitro Study. Viruses, 2022; 14(3):558. 

42.  Banerjee A & Mukherjee A#. Herpesviridae and microRNAs. In Current Perspectives on Viral Disease Outbreaks - Epidemiology, Detection and Control. Intechopen.com. 2021; DOI: 10.5772/intechopen.100370. 

43.  Nanaware N, Banerjee A, Mullick Bagchi S, Bagchi P, Mukherjee A#. Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses. Viruses, 2021; 13(10):1967. 

44.  Mukhopadhyay U, Banerjee A, Chawla-Sarkar M and Mukherjee A#. Rotavirus Induces Epithelial–Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b. Front Microbiol, 2021; 12:631183. 

45.  Klionsky DJ, et al. Among authors: Mukherjee A. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021; 17(1):1-382. 

46.  Banerjee A, Kulkarni S, Mukherjee A#. Herpes Simplex Virus: The Hostile Guest That Takes Over Your Home. Front Microbiol, 2020; 11:733. 

47.  Saha P, Biswas M, Gupta R, Majumdar A, Mitra S, Banerjee A, Mukherjee A, Dutta S, Chawla-Sarkar M. Molecular characterization of Influenza A pandemic H1N1 viruses circulating in eastern India during 2017-19: Antigenic diversity in comparison to the vaccine strains. Infect Genet Evol, 2020; 81:104270. 

48.  Mukhopadhyay U, Chanda S, Patra U, Mukherjee A, Komoto S, Chawla-Sarkar M. Bi-phasic regulation of RNA interference during Rotavirus infection by modulation of Argonaute2. Cellular Microbiology, 2019; 21(12):e13101. 

49.  Mukhopadhyay U, Chanda S, Patra U, Mukherjee A, Rana S, Mukherjee A#, Chawla-Sarkar M#. Synchronized Orchestration of miR-99b and let-7g Positively Regulates Rotavirus Infection by Modulating Autophagy. Scientific Reports, 2019; 9(1):1318. 

50.  Doan YH, Suzuki Y, Fujii Y, Haga K, Fujimoto A, Takai-Todaka R, Someya Y, Nayak MK, Mukherjee A, Imamura D, Shinoda S, Chawla-Sarkar M, Katayama K. Complex reassortment events of unusual G9P[4] rotavirus strains in India between 2011 and 2013. Infect Genet Evol, 2017; 54:417-428. 

51.  Mukherjee A, Nayak MK, Dutta S, Panda S, Satpati BR, Chawla-Sarkar M. Genetic Characterization of Circulating 2015 A(H1N1) pdm09 Influenza Viruses from Eastern India. PLoS ONE, 2016; 11(12):e0168464. 

52.  Mandal P, Mullick S, Nayak MK, Mukherjee A, Ganguly N, Niyogi P, Panda S, Chawla-Sarkar M. Complete genotyping of unusual species A rotavirus G12P[11] and G10P[14] isolates and evidence of frequent in vivo reassortment among the rotaviruses detected in children with diarrhea in Kolkata, India, during 2014. Arch Virol, 2016; 161(10):2773–2785. 

53.  Mukherjee A, Di Bisceglie AM, Ray RB. Hepatitis C Virus Mediated Enhancement of miR-373 Impairs JAK/STAT Signaling Pathway. J Virol, 2015; 89(6):3356-65. 

54.  Mukherjee A, Shrivastava S, Chowdhury JB, Ray R, Ray RB. Articles of Significant Interest Selected from This Issue by the Editors: Hepatitis C Virus-Mediated miR-181c Trans-Suppression Regulates Hepatocyte Growth. J Virol, 2014; 88(14):7691. 

55. Mullick S, Mukherjee A, Ghosh S, Pazhani GP, Sur D, Manna B, Nataro JP, Levine MM, Ramamurthy T, Chawla-Sarkar M. Community Based Case-Control Study of Rotavirus Gastroenteritis among Young Children during 2008-2010 Reveals Vast Genetic Diversity and Increased Prevalence of G9 Strains in Kolkata. PloS ONE, 2014; 9(11): e112970. 

56.  Ray RB, Mukherjee A, Shrivastava S, Ray R. Hepatitis C virus transcriptionally downregulates miR-181c for promotion of hepatocyte growth towards hepatocellular carcinoma. Cancer Research, 2014; 74(19): 3177-3177. 

57.  Mukherjee A, Shrivastava S, Chowdhury JB, Ray R, Ray RB. Transcriptional Suppression of miR-181c by Hepatitis C Virus Enhances Homeobox A1 Expression. J Virol, 2014; 88(14):7929-40. 

58.  Shrivastava S*, Mukherjee A*, Ray RB. Hepatitis C virus infection, microRNA and liver disease progression. World J Hepatol, 2013; 5(9): 479-86. 

59.  Shrivastava S*, Mukherjee A*, Ray R, Ray RB. Hepatitis C Virus Induces IL-1β/IL-18 in Circulatory and Resident Liver Macrophages. J Virol, 2013; 87(22):12284-90. 

60.  Kang G, Desai R, Arora R, Chitamabar S, Naik TN, Krishnan T, Deshpande J, Gupte MD, S Venkatasubramaniam, Gentsch JR, Parashar UD, Mathew A, Anita S, Ramani S, Sowmynarayanan TV, Moses PD, Agarwal I, Simon A, Bose A, Arora R, Chhabra P, Fadnis P, Bhatt J, Shetty SJ, Saxena VK, Mathur M, Jadhav A, Roy S, Mukherjee A, Singh NB. Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005-2009. Vaccine, 2013; 31(27):2879-2883. 

61.  Roy Mukherjee T, Mukherjee A, Chawla-Sarkar M. Full genomic analysis of human group C Influenza from eastern India. Infect Genet Evol, 2013; 16:419-25. 

62.  Chattopadhyay S, Basak T, Nayak MK, Bhardwaj G, Mukherjee A, Bhowmick R, Sengupta S, Chakrabarty O, Chatterjee NS, Chawla-Sarkar M. Identification of cellular calcium binding protein calmodulin as a regulator of rotavirus A infection during comparative proteomic study. PLoS ONE, 2013; 8(2): e56655. 

63.  Mullick S, Mukherjee A, Ghosh S, Pazhani GP, Sur D, Manna B, Nataro JP, Levine MM, Ramamurthy T, Chawla-Sarkar M. Genomic analysis of human rotavirus strains G6P[14] & G11P[25] isolated from Kolkata in 2009 reveals interspecies transmission and complex reassortment events. Infect Genet Evol, 2012; 14(1):15-21. 

64.  Mukherjee A, Mullick S, Deb AK, Panda S, Chawla-Sarkar M. First Report of Human Rotavirus G8P[4] Gastroenteritis in India: Evidence of Ruminants-to-Human Zoonotic Transmission. J Med Virol, 2012; 85:537–545. 

65.  Mukherjee A, Mullick S, Kobayashi N and Chawla-Sarkar M. The First Identification of Rare Human Group A Rotavirus Strain G3P[10] with Severe Infantile Diarrhea in Eastern India. Infect Genet Evol, 2012; 12(8):1933-7. 

66.  Mukherjee A, Chatopadhyay S and Chawla-Sarkar M. Rotavirus Infection in India: a major cause of childhood gastroenteritis. Proceedings of the National Academy of Science, India, 2012; 82(1):135–51. 

67.  Mukherjee A, Nayak MK, Roy T, Ghosh S, Naik TN, Kobayashi N, Chawla-Sarkar M. Detection of G10 Rotavirus Strains from Untypable Samples: Evidence for Interspecies Recombination in Human Group A Rotavirus Strains. Infect Genet Evol, 2012; 12(2):467-70. 

68.  Roy T, Agrawal AS, Mukherjee A, Mishra AC, Chadha MS, Kaur H, Chawla-Sarkar M. Surveillance and Molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India. Infect Genet Evol, 2011; 11(7):1595-601. 

69.   Mukherjee A, Ghosh S, Bagchi P, Dutta D, Chattopadhyay S, Kobayashi N, Chawla-Sarkar M. Full genomic analyses of human G4P[4], G4P[6], G9P[19] and G10P[6] strains from North-eastern India: Evidence for interspecies transmission and complex reassortment events. Clin Microbiol Infect, 2011; 17(9): 1343–6. 

70.  Dutta D, Chattopadhyay S, Bagchi P, Halder UC, Nandi S, Mukherjee A, Kobayashi N, Taniguchi K, Chawla-Sarkar M. Active participation of cellular chaperone Hsp90 in regulating the function of rotavirus nonstructural protein 3 (NSP3). J Biol Chem, 2011; 3; 286(22):20065-77. 

71.  Mukherjee A and Chawla-Sarkar M. Rotavirus Infection: A Perspective on Epidemiology, Genomic Diversity and Vaccine Strategies. Indian J Virol/VirusDiseases, 2011; 22(1):11–23. 

72.  Mukherjee A, Roy T, Agrawal AS, Sarkar M, Lal R, Chakrabarti S, Chawla-Sarkar M. Prevalence and epidemiology of pandemic H1N1 strains in hospitals of Eastern India.  J Pub Health Epidemiol, 2010; 2(7): 171-4. 

73.  Bagchi P, Dutta D, Chattopadhyay S, Mukherjee A, Halder UC, Sarkar S, Kobayashi N, Komoto S, Taniguchi K, Chawla-Sarkar M. Rotavirus Non-Structural Protein-1 suppresses virus induced cellular apoptosis to facilitate viral growth by activating the cell-survival pathways during early stages of infection. J Virol, 2010; 84(13):6834-45. 

74.  Mukherjee A, Chattopadhyay S, Bagchi P, Dutta D, Singh NB, Arora R, Parashar UD, Gentsch JR, Chawla-Sarkar M. Surveillance and molecular characterization of rotavirus strains circulating in Manipur, north-eastern India: Increasing prevalence of emerging G12 Strains. Infect Genet Evol, 2010; 10(2):311-20. 

75.  Chattopadhyay S, Bagchi P, Dutta D, Mukherjee A, Kobayashi N, Chawla-Sarkar M. Computational identification of the post-translational modification sites and the functional family prediction reveals possible moonlighting role of rotaviral proteins. Bioinformation, 2010; 4(10): 448-51. 

76.  Kang G, Arora R, Chitambar SD, Deshpande J, Gupte MD, Kulkarni M, Naik TN, Mukherji D, Venkatasubramaniam S, Gentsch JR, Glass RI, Parashar UD, Mathew A, Gonsalez A, Ramani S, Sowmynarayanan TV, Moses PD, Agarwal I, Simon A, Bose A, Arora R, Chhabra P, Fadnis P, Bhatt J, Shetty SJ, Saxena VK, Mathur M, Jadhav A, Roy S, Mukherjee A, Singh NB. Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis. 2009; 200 Suppl 1:S147-53. 

77.  Dutta D, Bagchi P, Chatterjee A, Nayak M K, Mukherjee A, Chattopadhyay S, Nagashima S, Kobayashi N, Satoshi K, Taniguchi K, Chawla-Sarkar M. The Molecular Chaperone Heat Shock Protein-90 Positively Regulates Rotavirus Infection. Virology, 2009; 391(2):325-33. 

78.  Mukherjee A, Dutta D, Ghosh S, Bagchi P, Chattopadhyay S, Nagashima S, Kobayashi N, Dutta P, Krishnan T, Naik TN, Chawla-Sarkar M. Full genomic analysis of a human group A rotavirus G9P[6] strain from Eastern India provides evidence for porcine to human interspecies transmission. Arch Virol, 2009; 154(5):733-46.